Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-10-21

FDA Approved: ZALEPLON — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for Zaleplon submitted by Bionpharma Inc. The approval confirms continued marketing of the generic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zaleplon (Zaleplon)

Snippet

SUPPL AP for ZALEPLON (ZALEPLON)